Skip to content
Monday 3 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
City PM

European business, markets and politics

FTSE 100
10,868.05
-0.27%
DAX
25,629.24
0.00%
CAC 40
8,509.64
0.00%
STOXX 50
6,358.01
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Sunday 29 August 2021 11:02 am  |  Updated:  Friday 05 November 2021 12:48 pm

Army major from Surrey to walk 1,200 miles barefoot to fund gene therapy treatment

By: Michiel Willems

Add as a preferred source on Google
Army major Chris Brannigan, from West Byfleet, Surrey, with injuries to his foot following a barefoot charity trek across the UK. The Army major is to march 1,200 miles barefoot across the US as part of a £2.5m campaign to fund a ground-breaking gene therapy treatment for his daughter. (Source: PA)

An Army major is to march 1,200 miles barefoot as part of a £2.5m campaign to fund a ground-breaking gene therapy treatment for his nine-year-old daughter.

Chris Brannigan, from West Byfleet, Surrey, is taking on the challenge to help pay for clinical trials of a potential treatment for the developmental disorder Cornelia de Lange syndrome (CdLS) which his daughter, Hasti, has been diagnosed with.

Major Brannigan has already walked 700 miles barefoot across the UK and raised £500,000 but will continue his campaign in the US, where the treatment is being developed.

This week

He will set off on Tuesday from Maine and head to North Carolina, visiting the laboratory developing the treatment and other sites linked to supporting children with CdLS.

He anticipates it will take 53 consecutive days to walk the 1,200 miles, travelling up to 35 miles a day while carrying a 25kg kit bag, including his one-man tent.

The 41-year-old said the fundraising challenge was essential for the creation of the new treatment.

He said: “It exists, it is on a shelf in a laboratory in Maine and we are currently about to start on efficacy trials, and all the staff are really optimistic about the kind of effect it will have.

Read more

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

“We are hoping we will be able to move straight into clinical trials early next year but that is dependant on us having the funds necessary, and hence I am undertaking this fundraising challenge.”

Describing the effect of CdLS on Hasti, he added: “It is multi-systemic so it affects Hasti in many different ways, it causes seizures, cognitive disability, learning disability, it has reduced Hasti’s growth velocity which means she is required to take daily growth hormone supplements.

“It affects her speech and language, she didn’t begin speaking until she was five so her ability to communicate is down. It means lots of things that other children find easy are quite difficult for Hasti, it’s quite isolating.”

He said that Hasti had been supporting his preparations for the trek and added: “She has been helping me to get ready and pack my bags, and over the last three weeks we have been going for walks together, which has been really good to spend time together but I hope she will miss me as I will be away for a couple of months.”

Maj Brannigan said that his previous barefoot trek in the UK had been “really painful” and led to multiple blisters and infections.

Maj Brannigan and his wife, Hengameh, have set up a GoFundMe page for sponsorship as part of their charity CdLS Hope For Hasti.

He said that the military community including at Upavon in Wiltshire, where he is based, had been extremely supportive and helped raise much of the money so far.

Read more

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Business

Trending Articles

  • Gino D’Acampo restaurants face HMRC winding-up order

  • Goldman Sachs criticises £1.45m paternity payout

  • BP quits North Sea after tax grab

  • Revolut will become $1 trillion company by 2035, says early VC backer

  • Healey announces early Budget

More from City PM

  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

    Business Wire
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

    Business Wire
  • UK’s biggest pub firm probed over treatment of tenants

    Hospitality
    Stonegate street scene with historic architecture, bustling crowds, and local shops, capturing vibrant city life ambiance.
CityPM

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About City PM
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 City PM Ltd · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook